Labrycor

Isoprenaline Hydrochloride, the active ingredient in Labrycor, is a beta‑adrenergic agonist presented as a sterile intravenous solution for use in acute cardiac and respiratory conditions. It increases heart rate and myocardial contractility and also relaxes bronchial smooth muscle, making it useful in managing bradyarrhythmias, heart block, asthma and bronchospasm.

GNH USA supplies Labrycor as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across all markets, with reliable logistics and dedicated customer support.

Isoprenaline Hydrochloride acts on the beta‑adrenergic system to treat several acute cardiac and respiratory disorders. - Bradyarrhythmias: restores adequate heart rate and improves cardiac output in patients with abnormally slow rhythms. - Heart block: increases conduction through the atrioventricular node, helping to overcome various degrees of block. - Asthma: relaxes bronchial smooth muscle, providing rapid relief of bronchospasm during acute attacks. - Bronchospasm: produces bronchodilation to improve airflow in severe bronchoconstriction episodes.

Isoprenaline Hydrochloride may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Tachycardia: rapid increase in heart rate. - Palpitations: sensation of irregular or forceful heartbeats. - Tremor: fine shaking of hands or limbs. - Headache: mild to moderate cranial pain.

Serious or Rare Side Effects: - Arrhythmias: potentially life‑threatening irregular heart rhythms. - Myocardial ischemia: reduced blood flow to heart muscle causing chest pain. - Severe bronchospasm paradox: unexpected worsening of airway constriction.

When using Isoprenaline Hydrochloride, careful monitoring and specific precautions are recommended to minimize risks. - Cardiac monitoring: continuous ECG and blood pressure should be observed during infusion. - Dose titration: start with the lowest effective dose and adjust gradually under medical supervision. - Contraindications: avoid use in patients with uncontrolled hyperthyroidism or severe hypertension. - Drug interactions: monitor closely when combined with other sympathomimetics or MAO inhibitors. - Store at ambient temperature: keep the solution below 25 °C, protected from light and moisture in the original container.

Isoprenaline Hydrochloride interacts with several medications that can amplify or diminish its pharmacologic effects.

Major Interactions (Avoid): - Beta‑blockers: antagonize the drug’s action, potentially causing severe bradycardia. - Calcium channel blockers: additive negative inotropic effects may precipitate heart failure.

Moderate Interactions (Monitor Closely): - MAO inhibitors: may enhance catecholamine effects, increasing risk of hypertension. - Diuretics: can cause electrolyte imbalances that affect cardiac response. - Anticholinergic agents: may reduce bronchodilatory efficacy.